[go: up one dir, main page]

ATE240114T1 - Muramylpeptide zusammensetzungen für inhibierung von hiv replikation - Google Patents

Muramylpeptide zusammensetzungen für inhibierung von hiv replikation

Info

Publication number
ATE240114T1
ATE240114T1 AT95932794T AT95932794T ATE240114T1 AT E240114 T1 ATE240114 T1 AT E240114T1 AT 95932794 T AT95932794 T AT 95932794T AT 95932794 T AT95932794 T AT 95932794T AT E240114 T1 ATE240114 T1 AT E240114T1
Authority
AT
Austria
Prior art keywords
inhibiting hiv
muramylpeptide
compositions
hiv replication
replication
Prior art date
Application number
AT95932794T
Other languages
English (en)
Inventor
Georges Bahr
Original Assignee
Vacsyn Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vacsyn Sa filed Critical Vacsyn Sa
Application granted granted Critical
Publication of ATE240114T1 publication Critical patent/ATE240114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT95932794T 1994-09-26 1995-09-26 Muramylpeptide zusammensetzungen für inhibierung von hiv replikation ATE240114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411460A FR2724845B1 (fr) 1994-09-26 1994-09-26 Compositions de muramyl peptides capables d'inhiber jusqu'a 100% la replication d'un virus de l'immuno-deficience acquise, tel que le vih
PCT/FR1995/001239 WO1996009837A1 (fr) 1994-09-26 1995-09-26 Compositions de muramylpeptides inhibant la replication du vih

Publications (1)

Publication Number Publication Date
ATE240114T1 true ATE240114T1 (de) 2003-05-15

Family

ID=9467271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932794T ATE240114T1 (de) 1994-09-26 1995-09-26 Muramylpeptide zusammensetzungen für inhibierung von hiv replikation

Country Status (11)

Country Link
EP (1) EP0783319B1 (de)
JP (1) JPH10506120A (de)
AT (1) ATE240114T1 (de)
AU (1) AU3569995A (de)
CA (1) CA2200993A1 (de)
DE (1) DE69530779T2 (de)
DK (1) DK0783319T3 (de)
ES (1) ES2197923T3 (de)
FR (1) FR2724845B1 (de)
PT (1) PT783319E (de)
WO (1) WO1996009837A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3006697A (en) * 1996-05-10 1997-12-05 Endorex Corporation Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
FR2809106A1 (fr) * 2000-05-17 2001-11-23 Istac Polypeptide ro/ssa-like et ses fragments et polynucleotides codant lesdits polypeptides et applications therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692148B3 (fr) * 1992-06-12 1994-08-19 Vacsyn France Sa Composition adjuvante de l'immunité humorale et à médiation cellulaire n'induisant pas de réponse vis-à-vis de déterminants auto-antigéniques.

Also Published As

Publication number Publication date
JPH10506120A (ja) 1998-06-16
AU3569995A (en) 1996-04-19
DE69530779T2 (de) 2004-03-25
DE69530779D1 (de) 2003-06-18
EP0783319B1 (de) 2003-05-14
ES2197923T3 (es) 2004-01-16
FR2724845B1 (fr) 1997-01-17
DK0783319T3 (da) 2003-09-15
FR2724845A1 (fr) 1996-03-29
PT783319E (pt) 2003-09-30
EP0783319A1 (de) 1997-07-16
CA2200993A1 (en) 1996-04-04
WO1996009837A1 (fr) 1996-04-04

Similar Documents

Publication Publication Date Title
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
BR9708632A (pt) Composto calcilìticos
ATE133181T1 (de) Dehydrodidemnin b
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
AR053946A2 (es) Variante de alfa-amilasa de bacillus stearothermophilus original
IT1287967B1 (it) Preparazioni farmaceutiche per uso anestetico locale
TR199801845T2 (xx) Dimerik fibroblast aktifle�tirici protein alfa ve kullan�mlar�.
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
ATE189527T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
BR0009696A (pt) Compostos esteróides ou seus sais, uso dos mesmos, e, formulações farmacêuticas
IT1285770B1 (it) Composti corticoidei
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
ATE239709T1 (de) Racemisches huperzin a
ES2162909T3 (es) Composiciones de fosfolipidos silicona modificadas.
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
DK0633763T3 (da) Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
ES2131528T3 (es) Nuevos polipeptidos y su uso.
HUP9900506A2 (hu) Protrombinszármazékok
ATE213937T1 (de) Spezielle halofantrinhaltige zusammensetzungen
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
ATE58639T1 (de) Appetit mildernde und gegen gastritis wirksame zusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0783319

Country of ref document: EP

REN Ceased due to non-payment of the annual fee